Ignite Creation Date:
2024-05-06 @ 2:42 AM
Last Modification Date:
2024-10-26 @ 11:22 AM
Study NCT ID:
NCT02109653
Status:
WITHDRAWN
Last Update Posted:
2020-11-13
First Post:
2014-03-25
Brief Title:
Efficacy and Safety of LGX818 in Patients With Advanced or Metastatic BRAF V600 Mutant NSCLC
Sponsor:
Array Biopharma now a wholly owned subsidiary of Pfizer
Organization:
Array BioPharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
None
Primary Completion Date:
2017-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-11
Completion Date Type:
ESTIMATED
First Submit Date:
2014-03-25
First Submit QC Date:
April 7 2014
Study First Post Date:
2014-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-11
Last Update Post Date:
2020-11-13
Last Update Post Date Type:
ACTUAL